Finance

Beta
Lists
603351:SHA
Nanjing Well Pharmaceutical Group Co Ltd
CN¥25.59
+1.95%
(+0.49) 1D
Jun 10, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603351...
Open
CN¥25.10
High
CN¥25.70
Low
CN¥24.77
Mkt. cap
3.40B
Avg. vol.
1.09M
Volume
890.81K
Dividend
2.34%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 5, 2026
P/E ratio
22.80
52-wk high
CN¥33.34
52-wk low
CN¥23.24
EPS
CN¥1.12
No. of employees
718
Open
CN¥25.10
High
CN¥25.70
Low
CN¥24.77
Mkt. cap
3.40B
Avg. vol.
1.09M
Volume
890.81K
Dividend
2.34%
Quarterly dividend
CN¥0.15
Ex-dividend date
Jun 5, 2026
P/E ratio
22.80
52-wk high
CN¥33.34
52-wk low
CN¥23.24
EPS
CN¥1.12
No. of employees
718
News stories
From sources across the web
About Nanjing Well Pharmaceutical Group Co Ltd
CEO-
Employees718
FoundedFeb 18, 2000
Headquarters-
SectorCommodity chemical
Websitewell-js.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
324.00M
344.52M
316.80M
356.30M
Cost of goods sold
229.36M
240.25M
232.82M
258.38M
Cost of revenue
229.36M
240.25M
232.82M
258.38M
Research and development expenses
19.95M
22.83M
20.55M
19.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.51M
33.00M
25.44M
27.73M
Operating expense
50.13M
54.62M
47.14M
48.21M
Total operating expenses
279.49M
294.87M
279.96M
306.58M
Operating income
44.51M
49.65M
36.83M
49.72M
Other non operating income
193.80K
-366.27K
220.72K
-2.06M
EBT including unusual items
42.91M
47.72M
39.07M
43.92M
EBT excluding unusual items
41.98M
46.87M
33.62M
43.93M
Income tax expense
7.37M
7.29M
1.82M
7.07M
Effective tax rate
17.18%
15.27%
4.65%
16.11%
Other operating expenses
455.92K
-1.05M
1.06M
506.84K
Net income
36.18M
41.30M
36.90M
37.63M
Net profit margin
11.17%
11.99%
11.65%
10.56%
Earnings per share
-
-
-
-
Interest and investment income
31.92K
267.66K
85.57K
113.84K
Interest expense
-3.03M
-2.41M
-2.32M
-3.85M
Net interest expenses
-3.00M
-2.14M
-2.23M
-3.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
75.20M
76.35M
67.52M
80.41M
Gain or loss from assets sale
-6.48K
6.48K
-16.25K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer